date
six
human
coronavirus
known
associ
respiratori
infect
human
except
highli
pathogen
sar
mer
coronavirus
human
coronavirus
circul
worldwid
typic
caus
common
cold
case
infect
virus
lead
sever
diseas
although
acut
infect
infant
elderli
immunocompromis
patient
may
progress
sever
diseas
requir
hospit
importantli
drug
human
coronavirus
exist
support
therapi
avail
previous
propos
cation
modifi
chitosan
n
chitosan
chlorid
htcc
hydrophobicallymodifi
deriv
hmhtcc
potent
inhibitor
coronaviru
show
htcc
inhibit
interact
viru
receptor
thu
block
entri
demonstr
htcc
polym
differ
degre
substitut
act
effect
inhibitor
lowpathogen
human
coronavirus
cell
cultur
cell
atcc
macaca
mulatta
kidney
epitheli
maintain
minim
essenti
medium
mem
two
part
hank
mem
one
part
earl
mem
life
technolog
poland
supplement
heatinactiv
fetal
bovin
serum
life
technolog
anticoronavir
htcc
plo
one
coronavirus
cov
largest
group
within
nidoviral
order
compris
mammalian
avian
pathogen
base
phylogenet
cluster
cov
sort
four
genera
alpha
beta
gamma
deltacoronavirus
alphaand
betacoronaviru
genera
encompass
six
human
pathogen
identifi
date
cov
envelop
positivestrand
rna
virus
larg
genom
approxim
kb
genom
rna
cap
polyadenyl
twothird
cov
genom
encod
polyprotein
posttransl
process
yield
protein
requir
rna
replic
nonstructur
protein
wherea
onethird
genom
encod
canon
set
four
structur
protein
spike
envelop
membran
nucleocapsid
glycoprotein
cov
belong
class
viral
fusion
protein
facilit
virusreceptor
interact
envelop
membran
protein
form
virion
shell
nucleocapsid
protein
interact
viral
rna
form
viru
core
speci
belong
betacoronaviru
genu
encod
addit
structur
protein
hemagglutinin
esteras
thought
act
receptordegrad
enzym
mediat
interact
coreceptor
depend
speci
human
cov
hcov
associ
respiratori
infect
two
known
caus
sever
lifethreaten
diseas
first
sever
acut
respiratori
syndrom
coronaviru
sarscov
infect
approxim
individu
mortal
rate
nearli
howev
viru
disappear
summer
never
return
highli
virul
form
second
recent
isol
cov
middl
east
respiratori
syndrom
coronaviru
merscov
caus
pneumonia
renal
failur
mortal
rate
exceed
remain
four
lowpathogen
lp
hcov
alphacoronavirus
betacoronavirus
shown
circul
worldwid
although
infect
virus
result
primarili
common
cold
otherwis
healthi
adult
may
caus
sever
diseas
young
elderli
immunocompromis
individu
date
effect
drug
avail
treat
infect
hcov
includ
sarscov
merscov
previous
propos
cation
modifi
chitosan
n
chitosan
chlorid
htcc
hydrophobicallymodifi
deriv
hmhtcc
potent
inhibitor
polymer
compound
abl
imped
replic
viru
vitro
permiss
cell
line
well
ex
vivo
model
fulli
differenti
human
airway
epithelium
hae
primari
cultur
furthermor
polym
shown
inhibit
murin
hepat
viru
mhv
infect
cultur
suggest
chitosanbas
compound
may
repres
novel
type
broadspectrum
inhibitor
dissect
mechan
htcc
antivir
activ
use
function
assay
molecular
method
flow
cytometri
confoc
microscopi
thorough
analysi
htcc
activ
prove
polym
interact
protein
block
interact
cellular
receptor
angiotensinconvert
enzym
type
protein
furthermor
show
htcc
differ
degre
substitut
dss
potent
inhibitor
four
lphcov
dss
express
fraction
nh
group
substitut
within
chitosan
chain
ds
studi
htcc
polym
vari
thu
polym
name
previous
describ
htcc
polym
ds
mark
demonstr
inhibitori
effect
also
interestingli
two
differ
htcc
prove
effect
inhibitor
infect
effect
inhibit
replic
show
strong
antivir
effect
infect
taken
togeth
current
analysi
demonstr
combin
cation
modifi
chitosanbas
polymer
compound
singl
formul
may
act
effect
broadrang
anticoronavir
agent
treatment
coronavir
infect
poland
penicillin
uml
streptomycin
ciprofloxacin
human
cell
atcc
maintain
life
technolog
poland
supplement
heatinactiv
fetal
bovin
serum
life
technolog
poland
penicillin
uml
streptomycin
ciprofloxacin
human
atcc
cell
maintain
dulbecco
mem
life
technolog
poland
supplement
heatinactiv
fetal
bovin
serum
life
technolog
poland
penicillin
uml
streptomycin
ciprofloxacin
cell
cultur
co
human
tracheobronchi
epitheli
cell
obtain
airway
specimen
resect
patient
undergo
surgeri
silesian
center
heart
diseasesapprov
protocol
studi
approv
bioethic
committe
medic
univers
silesia
katowic
poland
approv
date
particip
provid
written
inform
consent
particip
studi
approv
bioethic
committe
primari
cell
expand
plastic
gener
passag
cell
plate
permeabl
transwel
insert
support
human
airway
epithelium
hae
cultur
gener
provis
airliquid
interfac
week
form
welldifferenti
polar
cultur
resembl
vivo
pseudostratifi
mucociliari
epithelium
synthesi
htcc
perform
follow
g
chitosan
molecular
weight
kda
degre
deacetyl
dd
dispers
mixtur
ml
distil
water
ml
acet
acid
solut
stir
min
vari
volum
ml
glycidyltrimethylammonium
chlorid
gtmac
ad
obtain
polym
differ
ds
valu
vari
result
mixtur
heat
incub
h
stir
reflux
condens
suspens
subsequ
centrifug
rpm
min
remov
suspend
unreact
chitosan
product
separ
supernat
via
precipit
aceton
subsequ
centrifug
rpm
min
solut
decant
result
polymer
pellet
air
dri
dissolv
distil
water
purif
process
repeat
twice
purifi
htcc
dri
vacuum
oven
h
dss
polym
obtain
given
tabl
stock
isol
amsterdam
gener
infect
monolay
cell
atcc
ncpv
plate
incub
day
cytopath
effect
cpe
score
observ
invert
microscop
isol
replic
analyz
realtim
rtpcr
strain
caen
propag
fulli
differenti
hae
cultur
previous
describ
viru
replic
analyz
realtim
rtpcr
viru
stock
concentr
use
centrifug
protein
concentr
amicon
ultra
kda
cutoff
merck
poland
subsequ
overlaid
iodixanol
solut
pb
optiprep
medium
sigmaaldrich
poland
follow
viru
concentr
use
iodixanol
cushion
centrifug
g
h
overlaid
iodixanol
gradient
pb
centrifug
g
h
fraction
ml
collect
gradient
analyz
western
blot
follow
immunodetect
nucleocapsid
protein
viruscontain
fraction
aliquot
store
control
cell
lysat
mock
concentr
prepar
manner
viru
stock
subsequ
vitro
experi
fulli
confluent
cell
plate
tpp
expos
respect
tcid
presenc
test
polym
control
medium
mem
dmem
follow
h
incub
unbound
virion
remov
wash
pb
fresh
medium
contain
dissolv
respect
polym
ad
well
sampl
cell
cultur
supernat
collect
day
pi
analyz
realtim
rtpcr
ex
vivo
studi
fulli
differenti
human
airway
epithelium
hae
cultur
expos
test
polym
control
pb
min
follow
inocul
presenc
polym
control
pb
follow
h
incub
unbound
virion
remov
wash
pb
hae
cultur
maintain
airliquid
interphas
rest
experi
analyz
viru
replic
kinet
day
pi
pb
appli
apic
surfac
hae
collect
follow
min
incub
sampl
store
analyz
realtim
rtpcr
cell
cultur
plate
describ
cell
viabil
assay
perform
use
xtt
cell
viabil
assay
biolog
industri
israel
accord
manufactur
instruct
day
assay
medium
remov
cultur
medium
activ
xtt
solut
ad
well
follow
h
incub
medium
transfer
onto
new
plate
signal
measur
nm
use
colorimet
spectra
max
molecular
devic
obtain
result
normal
control
sampl
cell
viabil
set
assess
cell
viabil
human
airway
epithelium
hae
cultur
apic
surfac
wash
pb
pb
activ
xtt
solut
appli
plate
incub
h
apic
liquid
transfer
new
plate
signal
measur
describ
viral
nucleic
acid
isol
cell
cultur
supernat
use
total
rna
miniprep
super
kit
bio
basic
canada
accord
manufactur
instruct
revers
transcript
carri
high
capac
cdna
revers
transcript
kit
life
technolog
poland
accord
manufactur
instruct
viru
yield
determin
use
realtim
pcr
fast
realtim
pcr
machin
life
technolog
poland
viral
cdna
per
sampl
amplifi
reaction
mixtur
contain
taqman
univers
pcr
master
mix
life
technolog
poland
specif
probe
label
fam
tamra
nm
primer
nm
rox
use
refer
dye
primer
probe
list
tabl
reaction
condit
follow
min
min
follow
cycl
sec
min
order
assess
copi
number
hcov
rna
standard
prepar
briefli
n
gene
amplifi
clone
thermo
scientif
poland
plasmid
use
instaclon
pcr
clone
kit
thermo
scientif
poland
subsequ
dna
vector
amplifi
linear
ecori
restrict
enzym
linear
nucleic
acid
purifi
pcr
purif
kit
thermo
scientif
poland
use
templat
vitro
transcript
use
rna
polymeras
thermo
scientif
poland
reaction
conduct
accord
manufactur
instruct
result
rna
dnase
treat
dnase
turbo
life
technolog
poland
purifi
total
rna
miniprep
super
kit
bio
basic
canada
accord
manufactur
instruct
concentr
assess
use
spectrophotomet
number
rna
copiesml
assess
use
avogadro
constant
molecular
mass
rna
molecul
sampl
serial
dilut
use
input
revers
transcript
realtim
pcr
reaction
cell
seed
plate
tpp
cultur
day
co
visual
adher
particl
cell
wash
pb
incub
iodixanolconcentr
mock
sampl
presenc
control
pb
h
subsequ
cell
wash
steril
pb
fix
pfa
permeabil
triton
pb
incub
h
bsa
pb
tween
assess
adhes
cell
scrape
plastic
incub
h
room
temperatur
mous
antibodi
ingenansa
spain
follow
h
incub
alexa
fluor
goat
antimous
antibodi
molecular
probe
cell
wash
resuspend
pb
analyz
fac
calibur
becton
dickinson
use
cell
quest
softwar
cell
seed
coverslip
plate
tpp
cultur
day
subsequ
cell
wash
pb
incub
iodixanolconcentr
mock
sampl
presenc
control
pb
h
cell
wash
pb
fix
pfa
permeabil
triton
pb
incub
overnight
pb
supplement
bsa
tween
visual
adher
particl
cell
incub
h
room
temperatur
mous
igg
ingenansa
spain
follow
h
incub
alexa
fluor
goat
antimous
igg
life
technolog
poland
stain
cell
incub
h
room
temperatur
goat
ectodomain
igg
r
system
usa
follow
h
incub
alexa
fluor
donkey
antigoat
igg
life
technolog
poland
nuclear
dna
stain
dapi
sigmaaldrich
poland
immunostain
cultur
mount
glass
slide
prolong
gold
antifad
medium
thermo
scientif
poland
fluoresc
imag
acquir
leica
tc
ii
confoc
microscop
leica
microsystem
gmbh
mannheim
germani
imag
acquir
use
leica
applic
suit
advanc
fluoresc
la
af
v
leica
microsystem
cm
gmbh
deconvolv
huygen
essenti
packag
ver
scientif
volum
imag
bv
netherland
process
use
imagej
nation
institut
health
bethesda
maryland
usa
experi
perform
triplic
result
present
mean
sd
determin
signific
obtain
result
comparison
group
conduct
use
oneway
anova
test
p
valu
consid
signific
first
aim
studi
investig
mechan
action
previous
describ
polym
analyz
influenc
differ
step
replic
cycl
first
determin
whether
polym
interact
directli
virion
achiev
concentr
viru
stock
incub
polym
control
pb
room
temperatur
h
subsequ
sampl
dilut
time
polym
concentr
activ
rang
titrat
describ
reed
muench
titer
evalu
day
pi
decreas
viru
titer
observ
polym
compar
control
sampl
data
shown
effect
viru
adhes
suscept
cell
evalu
briefli
cell
precool
incub
gradientpurifi
h
presenc
control
pb
temperatur
viru
bind
receptor
viru
intern
suppress
due
intracellular
traffick
inhibit
next
cell
surfac
adhes
evalu
use
flow
cytometri
viru
adher
inhibit
presenc
suggest
polym
hamper
viru
bind
heparan
sulfat
proteoglycan
hsp
fig
surprisingli
adher
particl
seem
enhanc
presenc
htcc
one
may
assum
virion
cluster
presenc
htcc
bind
polym
via
protein
form
aggreg
support
data
anoth
assay
perform
cell
precool
incub
tcid
h
presenc
control
pb
next
cultur
media
contain
unbound
viru
remov
cell
rins
time
ice
cold
pb
viru
infect
evalu
day
pi
base
occurr
cytopath
effect
cpe
quantit
rtpcr
obtain
result
demonstr
inhibit
adhes
virion
cell
surfac
data
shown
wherea
hsp
establish
primari
bind
site
viru
requir
presenc
function
receptor
next
step
aim
test
whether
block
interact
analyz
viru
coloc
receptor
presenc
control
pb
natur
suscept
cell
express
low
level
protein
use
previous
describ
cell
direct
express
briefli
cell
incub
gradientpurifi
presenc
control
pb
subsequ
cell
fix
immunostain
nucleoprotein
use
specif
antibodi
viru
coloc
receptor
examin
use
confoc
microscopi
obtain
result
demonstr
control
sampl
virion
coloc
protein
presenc
polym
interact
abolish
fig
result
consist
previou
observ
bind
protein
ensur
block
interact
main
mechan
htcc
antivir
activ
analyz
effect
use
also
function
assay
first
analyz
whether
polym
affect
intern
suscept
cell
interact
indispens
briefli
precool
cell
inocul
icecold
tcid
incub
h
allow
viru
bind
intern
next
viru
particl
remov
wash
icecold
pb
cell
incub
control
medium
h
enabl
viru
penetr
evalu
whether
polym
interfer
process
subsequ
media
remov
cell
wash
time
acid
buffer
glycin
nacl
ph
order
inhibit
fusogen
activ
virion
intern
effici
viru
deactiv
use
low
ph
verifi
prior
experi
data
shown
subsequ
cell
wash
pb
ph
overlaid
cultur
medium
cell
incub
day
occurr
cpe
day
pi
evalu
viru
yield
cell
cultur
supernat
measur
use
quantit
rtpcr
first
cpe
visibl
cultur
incub
polym
control
cultur
obviou
sign
viru
replic
visibl
qrtpcr
analysi
confirm
qualit
result
decreas
viru
yield
observ
sampl
treat
polym
compar
control
cell
fig
next
aim
studi
evalu
antivir
activ
previous
describ
polym
lphcov
employ
primari
hae
cultur
mimic
natur
respiratori
tract
microenviron
briefli
fulli
differenti
hae
cultur
infect
presenc
control
pb
follow
inocul
apic
lavag
sampl
collect
daili
replic
kinet
viru
investig
analysi
reveal
polym
hamper
infect
affect
replic
inhibitori
effect
evid
h
pi
effect
replic
perman
fig
importantli
signific
cytotox
observ
xtt
assay
five
cation
deriv
chitosan
obtain
tabl
react
chitosan
gtmac
substitut
chitosan
free
amino
group
gtmac
moieti
contain
amino
group
impart
stabl
ie
independ
ph
posit
charg
chitosan
macromolecul
improv
solubl
neutral
ph
ds
compound
determin
use
titrat
method
describ
valid
literatur
method
base
conductimetr
titrat
chlorid
ion
present
polym
use
silver
nitrat
solut
second
aim
studi
investig
differ
dss
affect
effect
analyz
effect
differ
variant
htcc
infect
seri
experi
conduct
take
consider
costeffect
limit
avail
primari
cultur
three
four
experi
perform
vitro
use
follow
permiss
cell
line
antivir
effect
htcc
polym
infect
investig
use
ex
vivo
hae
model
permiss
cell
line
avail
viru
vitro
experi
cell
seed
monolay
plate
infect
respect
cov
tcid
presenc
htcc
variou
ds
ml
control
media
incub
day
reduct
cpe
suscept
cell
investig
viru
yield
analyz
cell
cultur
supernat
analysi
reveal
infect
studi
pathogen
effect
inhibit
least
two
compound
replic
cell
reduc
previous
describ
also
similarli
infect
cell
effect
inhibit
promin
inhibitori
effect
observ
approxim
log
reduct
viru
yield
compar
control
sampl
hand
htcc
two
differ
dss
inhibit
infect
cell
compar
effect
approxim
log
reduct
viru
yield
compar
control
sampl
inhibit
infect
observ
fig
studi
effect
htcc
infect
hae
cultur
infect
viru
concentr
rna
copiesml
presenc
select
htcc
polym
control
pb
unfortun
titrat
viru
possibl
due
lack
appropri
vitro
cultur
model
analysi
reveal
studi
htcc
polym
affect
infect
effect
h
pi
log
decreas
yield
observ
sampl
supplement
compar
control
fig
ensur
observ
effect
result
cytotox
effect
polym
xtt
assay
perform
experiment
set
analysi
clearli
show
viabil
cell
line
hae
cultur
significantli
affect
test
polym
test
concentr
fig
current
vaccin
antivir
drug
avail
prevent
treat
hcovrel
diseas
includ
lifethreaten
diseas
result
sarscov
merscov
infect
consid
sever
infect
caus
aforement
pathogen
preval
remain
four
hcov
develop
effect
antivir
treatment
great
import
show
previous
cation
modifi
chitosan
hydrophobicallymodifi
deriv
potent
antivir
agent
polym
also
inhibit
mhv
infect
vitro
suggest
even
broader
antivir
activ
spectrum
chitosana
linear
hetropolysaccharid
deriv
chitin
previous
shown
antiinflammatori
properti
use
drug
deliveri
tissu
regener
propos
chitosan
antibacteri
activ
porphyromona
gingivali
aggregatibact
actinomycetemcomitan
actinobacillu
actinomycetemcomitan
streptococcu
mutan
pseudomona
aeruginosa
staphylococcu
aureu
current
studi
analyz
mechan
htcc
antivir
activ
thorough
analysi
reveal
polym
affect
viru
attach
target
cell
via
hsp
effect
block
subsequ
interact
cellular
receptor
obtain
result
consist
previou
report
demonstr
strong
interact
polym
recombin
ectodomain
protein
importantli
current
manuscript
previous
describ
htcc
polym
substitut
dss
rang
success
inhibit
infect
test
lphcov
inhibitori
activ
polym
evalu
vitro
use
permiss
cell
line
except
well
ex
vivo
primari
hae
cultur
unfortun
due
lack
appropri
anim
model
lphcov
vivo
analysi
possibl
present
result
analys
demonstr
potent
inhibitor
hand
polym
ds
rang
pb
control
viru
replic
cell
cultur
supernat
cell
line
apic
lavag
hae
evalu
use
quantit
rtpcr
data
present
log
remov
valu
lrv
compar
untreat
sampl
assay
perform
triplic
averag
valu
standard
error
present
p
b
cytotox
htcc
ds
rang
cell
line
hae
cultur
cell
viabil
assess
via
xtt
assay
data
yaxi
repres
percentag
valu
obtain
untreat
refer
sampl
assay
perform
triplic
least
two
independ
experi
averag
valu
standard
error
present
differ
cytotox
htcc
statist
signific
prove
effect
inhibitor
surprisingli
although
close
rel
inhibit
polym
differ
ds
similarli
hamper
replic
three
evolutionarili
distinct
virus
alphacoronaviru
belong
betacoronaviru
genu
data
analysi
show
inhibit
viru
requir
htcc
optim
ds
suggest
htcc
need
finetun
interact
viral
fusion
protein
conclus
studi
clearli
show
polymer
compound
base
chitosan
test
effici
inhibit
infect
hcov
interestingli
use
model
system
determin
htcc
polym
block
interact
protein
cellular
receptor
consequ
hamper
viru
infect
fact
polym
differ
substitut
level
activ
differ
cov
suggest
compound
interact
protein
differ
virus
may
optim
activ
also
speci
thu
htcc
hold
great
promis
anticoronavir
agent
use
treatment
respiratori
tract
infect
importantli
chitosan
chitosanbas
polym
toxic
vivo
shown
yeh
et
al
zeng
et
al
demonstr
htcc
rapidli
absorb
gastrointestin
tract
polym
mainli
distribut
lung
heart
kidney
wherea
hour
later
fulli
elimin
properti
make
htcc
promis
compound
use
clinic
potenti
htcc
highlight
fact
activ
substanc
first
broadrang
medicin
product
approv
treatment
respiratori
infect
fact
polym
iotacarrageenan
worth
note
howev
polym
effect
cov
unpublish
data
develop
htccbase
therapeut
may
offer
solut
